Talcum Powder Lawsuit: Guide & Latest Updates (2026)

2026 Talcum Powder Settlement News

Johnson & Johnson (J&J) continues to face legal pressures related to its talcum powder products. As of October 1, 2026, 69,340 cases were pending in the talc multidistrict litigation (MDL) in New Jersey.

These lawsuits allege that prolonged use of talcum powder products, such as Johnson's Baby Powder, caused ovarian cancer in some users. On July 27, 2026, J&J announced a deal with lead plaintiff firms to resolve about 76,000 remaining ovarian cancer claims through per-claim payments backed by a $5.5 billion commitment.

The deal only takes effect if at least 95% of those claims sign on. By October 7, 2026, 313 law firms representing over 66,500 claimants had joined the Talc Claims Resolution Program, which a court order called uncapped with a guaranteed minimum of $5.8 billion. J&J said the first payment will be no more than $3 billion in 2027. The company still denies that its talc causes cancer.

Bankruptcy Judge Rejects J&J’s Settlement Plan

On March 31, 2025, U.S. bankruptcy judge Christopher Lopez denied Johnson & Johnson’s roughly $8 billion settlement proposal, citing flaws in the voter solicitation process used to gain plaintiff support. This is now the third failed attempt by J&J to resolve talc lawsuits through bankruptcy proceedings.

J&J’s subsidiary, Red River Talc LLC, aimed to finalize a prepackaged Chapter 11 bankruptcy plan worth roughly $8 billion in present value to resolve current and future ovarian cancer talc claims. After the plan failed, J&J said it would fight the claims in court.

The rejection of the settlement plan has left almost 70,000 lawsuits unresolved. J&J has reversed $7 billion previously reserved for settlements, further undermining the resolution process.

Johnson & Johnson chose not to appeal the outcome of its third failed bankruptcy case, and the talcum powder lawsuits returned to the courts. Since July 29, 2026, however, all MDL deadlines have been on hold while claimants decide whether to join a global settlement.

J&J Challenges Expert Witness

An article in the biotech magazine Fierce Pharma points out that after its failed bankruptcy case, J&J is now shifting strategy and targeting expert witness Dr. Jacqueline Moline, who has testified in over 200 talc-related cases. The company has filed a motion to reopen a lawsuit against Moline, alleging that her research linking talc to asbestos exposure is flawed and misleading.

J&J originally sued Moline in 2022, but the case was dismissed in 2024. However, after winning an appeal to review her research data, J&J now claims that at least half of the study participants in her 2019 paper had other asbestos exposure sources, such as insulation and cigarette smoke.

The company argues that her findings are “completely false” and have wrongfully influenced litigation. This move signals J&J’s aggressive defense strategy as it now faces tens of thousands of talc lawsuits in court.

In a separate trade libel suit, J&J subsidiary Pecos River Talc accused three experts who testify for talc plaintiffs of publishing an article built on false facts. On August 20, 2026, the court ruled against Pecos River at summary judgment, and J&J said it would appeal.

New Study Confirms Talcum Powder Cancer Link

A study published in the Journal of Clinical Oncology in 2024 supports the claim of plaintiffs, finding a significant association between talc use and ovarian cancer. The study, conducted by researchers from the National Institutes of Health, enrolled over 50,000 women in the U.S. between 2003 and 2009.

J&J has consistently denied that its talc products contain asbestos or cause cancer, arguing that studies have not demonstrated a convincing link. However, this new research could undermine J&J’s defense as the legal battles continue.

In the MDL, Special Master Freda L. Wolfson recommended in January 2026 that plaintiffs’ experts be allowed to testify that studies show a significant tie between genital talc use and ovarian cancer, though J&J appealed. In July 2026, the court granted J&J’s motion for an order requiring plaintiffs to show they can prove talc caused their own ovarian cancer.

Talcum Powder & Ovarian Cancer

Talcum is in almost everything. That fact is why the link between it and cancer is so concerning.

What is Talcum Powder?

Talcum, the main component of talcum powder, primarily comprises magnesium, silicon, and oxygen. Its most prominent use is as a personal care product applied to the skin, commonly used to absorb moisture, reduce friction, and prevent chafing. Talcum’s unique properties make it incredibly versatile, finding application across several industries, including cosmetics, plastics, pharmaceuticals, and more.

Talcum is a primary ingredient in:

• Baby powder. Known for its gentle and absorbent qualities, talcum is a staple in baby powders, used to prevent diaper rash and keep an infant’s skin dry and soft.
• Body and facial powders. Talcum provides the base for many products designed to absorb excess moisture and provide a smooth, matte finish for the skin.
• Cosmetics. Talcum helps achieve a matte and velvety appearance when used in cosmetics such as eyeshadow, highlighter, and contour palettes.
• Plastics and ceramics. Its ability to enhance a material’s texture, stability, and thermal and electrical resistance makes talc a critical component in manufacturing various plastic compounds, ceramics, and industrial coatings.
• Paints. Talcum is a filler in paint production, enhancing properties like opacity, sheen, and stability.
• Pharmaceutical. In the pharmaceutical industry, talcum lubricates processes in medication production. It can also serve as an inactive ingredient to improve the texture of certain drugs or as a glidant, enhancing the flow properties of powdered substances.

Research Regarding Talcum Powder Safety

However, talcum is also questionable. The regulation of talcum powder has been a subject of ongoing scrutiny.

For years, research established a link between talcum and potential asbestos contamination. In 2020, the U.S. Food and Drug Administration (FDA) tested talc-containing cosmetic products for asbestos. It discovered that nine out of 52 samples showed the presence of asbestos, a naturally occurring fibrous silicate mineral known to cause cancer.

Illness related to talcum powder use include:

• Ovarian Cancer. A 2016 study published in the National Library of Medicine analyzed case-control data collected over 16 years and found that women who regularly used talc in the genital area had a 33% higher risk of developing ovarian cancer than those who didn’t.
• Respiratory diseases and lung cancer. Talcum powder, if inhaled over the long term, can cause respiratory difficulties and chronic lung disease, also known as pulmonary talcosis and lung cancer. It is essential to watch out for talcum powder poisoning symptoms for those inhaling it over long periods.
• Mesothelioma: Most notably, asbestos fibers in older versions of talcum powder could lead to mesothelioma, a rare form of cancer affecting the lining of the lung or abdomen. People with this condition often seek mesothelioma attorney assistance to recover the compensation they need for treatment.
• Cervical Cancer: Exposure to talcum powder may cause cervical cancer in the same way it causes ovarian cancer. Using it near the genital region allows cancerous elements to reach the reproductive system. However, this issue requires more research, and in January 2026 the MDL judge dismissed listed claims based on gynecologic cancers other than ovarian cancer.

What is the Talcum Powder Lawsuit?

The cancer links to talcum powder lead to lawsuits by those suffering conditions from its use. Talcum powder ovarian cancer lawsuits are part of a multi-district litigation (MDL No. 2738) in the U.S. District Court for the District of New Jersey, while many mesothelioma cases have gone to trial in state courts.

As of October 1, 2026, 69,340 cases were pending in the talc MDL. After a bankruptcy court rejected J&J’s roughly $8 billion plan in March 2025, J&J announced a new global deal in July 2026 to resolve the remaining ovarian cancer claims.

This case continues to move forward, especially since the World Health Organization confirmed the cancer risk with talcum powder. Recent trial results have been mixed: J&J has lost several mesothelioma trials but won others, including the Pelley and Smith cases in 2026.

Johnson & Johnson Settlements and Verdicts

The first lawsuit alleging a link between cancer and talcum powder was filed in 2013. How long does it take to settle a talcum powder case? These first cases took several years to resolve. But as the pace of talcum powder lawsuits picked up, J&J has used a combination of bankruptcy filings and rigorous attempts to settle as many claims as possible to try to save itself from financial ruin.

Determining an average settlement for talcum powder lawsuits is challenging because talcum powder settlement amounts and damage awards have been all over the map throughout the past decade. For years, J&J has tried unsuccessfully to settle the lawsuit, and it’s often increased the value of the proposed settlement to entice more plaintiffs to settle.

In May 2024, J&J proposed a $6.475 billion bankruptcy plan, later raised to roughly $8 billion, but a bankruptcy court rejected it in March 2025. On July 27, 2026, J&J announced a new deal backed by a $5.5 billion commitment, and a court order later put the program’s guaranteed minimum at $5.8 billion.

Past Settlements

What’s an average settlement for talcum powder lawsuits? You should not rely on past settlements to predict future outcomes. But the latest news on talcum powder lawsuits includes some proposed settlements that have been publicly announced, including J&J’s failed bankruptcy plan. In June 2024, J&J also settled with 43 state attorneys general for $700 million over its talc marketing, but that deal did not cover personal injury claims.

J&J had proposed settling roughly 50,000 cases by creating a settlement fund of roughly $8.9 billion. This averages to about $178,000 per claimant, although the fund presumably would have had an application process to pay more to certain claimants, such as those who died or have terminal diagnoses, than others.

A New Jersey bankruptcy court dismissed that bankruptcy case in July 2023, and the Third Circuit later agreed it lacked good faith because J&J’s talc unit, LTL Management, was not in financial distress. However, many plaintiffs objected to the low payouts for serious injuries that required expensive cancer treatments.

In July 2026, J&J announced a new global deal to resolve the remaining ovarian cancer claims.

Past Verdicts

In June 2024, an Oregon jury awarded $260 million to Kyung Lee, a woman who developed mesothelioma after using talcum powder since she was a baby. In September 2024, the trial judge vacated the $260 million verdict, according to J&J.

In April 2024, a court ordered J&J (and related company Kenvue Inc) to pay $45 million to the family of Theresa Garcia. She died of mesothelioma after using J&J talc products. On July 10, 2026, a divided Illinois appeals court let the Garcia verdict stand, and J&J said it would seek further review.

In 2018, Ann Zoas settled with J&J for $1.5 million. Her claim was based on mesothelioma that was caused by talcum products.

Also, in 2018, J&J lost a jury trial in Missouri. The jury awarded $4.69 billion to 22 women who suffered ovarian cancer. In 2020, an appeal court reduced the award to $2.1 billion but also threw out 17 of the 22 plaintiffs. Thus, the final verdict was $2.1 billion, shared by five plaintiffs. In June 2021, the U.S. Supreme Court declined to hear J&J’s appeal, and J&J paid the award, about $2.5 billion with interest.

Soon after the 2020 appeal decision, J&J offered to settle 1,000 cases for $100 million. Even after this settlement, J&J still faced 2,000 additional cases.

In October 2021, J&J shifted tactics. Realizing its liability for talcum powder injuries could ruin the company, J&J had its new talc unit, LTL Management, file for bankruptcy. At the time of this move, J&J had 38,000 talcum powder lawsuits pending against it. The move to bankruptcy would have created a fund for settling claims of $2 billion or about $52,600 per plaintiff. In January 2023, the Third Circuit ordered the case dismissed.

One of the few trials during J&J’s bankruptcy gambit occurred in California in 2023. A jury awarded $18.8 million to a 24-year-old man, Emory Hernandez Valadez, who claimed that J&J’s products caused a deadly form of mesothelioma that damaged the membrane surrounding the heart. Sadly, media reports suggest that Mr. Valadez would not see a Johnson and Johnson settlement check in 2023 due to his failing health.

More recent trials have gone both ways. In December 2025, a Baltimore court entered judgments totaling $1,559,840,000 after J&J lost the Craft trial, and a Minnesota jury awarded $65,540,627 in the Carley mesothelioma case. In March 2026, a judge struck the $950 million punitive award in the Moore case. J&J lost the Lozano and Roy mesothelioma trials in 2026 but won the Yandell, DuBois, Pelley and Smith trials.

Has Johnson & Johnson Settled the Remaining Lawsuits?

After the bankruptcy court rejected J&J’s bankruptcy plan, lawsuits over talc-related cancers resumed in both federal and state courts. On July 27, 2026, J&J announced a global deal with lead plaintiff firms in the MDL and coordinated state cases to resolve about 76,000 remaining ovarian cancer claims. Since July 29, 2026, the court has kept all MDL deadlines on hold while claimants decide whether to join, and no trial date is set.

A mediation session was held in the federal MDL. Mediation is sometimes referred to as guided negotiation. A mediator facilitates communication between the parties, attempting to identify common ground. In some cases, this process can help the parties realize that their negotiating positions overlap, leading to lawsuit settlements that are mutually acceptable.

Who Qualifies for a Talcum Powder Lawsuit?

The order that transferred all federal cases to the U.S. District Court in New Jersey for handling as an MDL specifically referenced ovarian cancer. Thus, joining the MDL requires an ovarian cancer diagnosis. In January 2026, Judge Shipp dismissed listed MDL cases based on gynecologic cancers other than ovarian cancer.

Everyone who suffered other injuries or diseases from the use of talc products can pursue personal injury lawsuits. However, these cases will not be included in the MDL. Instead, these plaintiffs will file individual lawsuits in state or federal courts.

How to Strengthen Your Talcum Powder Claim

There’s no way to guarantee that you’ll be one of the people who walks away from the courtroom with a multimillion-dollar settlement. However, there are steps you can take to increase your chances of receiving fair compensation. These are a few ways to strengthen your lawsuit:

Gather Evidence That You Used Talcum Powder

Receipts, photos with talcum powder in the background and similar pieces of evidence are all useful. The longer the period of time where you can prove you used the product, the greater your likelihood of fair compensation.

Have a Record of Your Cancer Diagnosis

To qualify for compensation, you must have been diagnosed with a type of cancer that is related to talcum powder. If your doctor believes talcum powder caused your cancer, that can help your case, since the MDL court has asked plaintiffs to show they can prove talc caused their own ovarian cancer.

Tracking Expenses

To receive compensation for damages (like medical bills and lost wages), you must have a detailed breakdown of your cancer-related costs.

Is It Too Late to File a Johnson and Johnson Talcum Powder Lawsuit?

The courts did not report a talcum powder lawsuit deadline. Cases progressed with new claims, trials, and a proposed global settlement after J&J’s bankruptcy attempts failed. There remains controversy as Johnson and Johnson fights with its previous lawyers and faces accusations of abusing the bankruptcy system.

In July 2026, J&J announced a deal to resolve the remaining ovarian cancer claims in the mass tort, and a later court order put the program’s guaranteed minimum at $5.8 billion. An attorney can tell you whether your claim may still qualify.

In all likelihood, you can still file a talcum powder ovarian cancer lawsuit. The best course of action is to file a claim sooner rather than later while claimants are still joining the global settlement. ConsumerShield can help you start the process by connecting you with an experienced attorney who can evaluate your claim. Start by filling out our free case review form.